Melanosomal Targeting Sequences from gp100 Are Essential for MHC Class II–Restricted Endogenous Epitope Presentation and Mobilization to Endosomal Compartments
Open Access
- 15 February 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (4) , 2423-2432
- https://doi.org/10.1158/0008-5472.can-05-2516
Abstract
CD4+ T lymphocytes play an important role in CD8+ T cell–mediated responses against tumors. Considering that ∼20% of melanomas express MHC class II, it is plausible that concomitant presentation by MHC class I and class II shapes positive (helper T cells) or negative (regulatory T cells) antitumor responses. Interestingly, gp100, a melanoma antigen, can be presented by both MHC class I and class II when expressed endogenously, suggesting that it can reach endosomal/MHC class II compartments (MIIC). Here, we showed that gp100 putative NH2-terminal signal sequence and the last 70 residues in COOH terminus are essential for MIIC localization and MHC class II presentation. Confocal microscopy analyses confirmed that gp100 was localized in LAMP-1+/HLA-DR+ endosomal/MIIC. Gp100 targeting sequences were characterized by deleting different sections in the COOH terminus (last 70 residues). Transfection in 293T cells, expressing MHC class I and class II molecules, revealed that specific deletions in COOH terminus resulted in decreased MHC class II presentation, without effects on class I presentation, suggesting a role in MIIC trafficking for these deleted sections. Then, we used these gp100 targeting sequences to mobilize green fluorescent protein to endosomal compartments and to allow MHC class II and class I presentation of minimal endogenous epitopes. We conclude that these specific sequences are MIIC-targeting motifs, which could be included in expression cassettes for endogenously expressed tumor or viral antigens for MHC class II and class I presentation and optimize in vivo T-cell responses or as an in vitro tool for characterization of new MHC class II epitopes. (Cancer Res 2006; 66(4): 2423-32)Keywords
This publication has 39 references indexed in Scilit:
- Primary Antitumor Immune Response Mediated by CD4+ T CellsImmunity, 2005
- Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected MelanomaClinical Cancer Research, 2004
- Correspondence re R. Lapointe et al ., CD40-stimulated B Lymphocytes Pulsed with Tumor Antigens Are Effective Antigen-presenting Cells That Can Generate Specific T Cells. Cancer Res 2003;63:2836–43.Cancer Research, 2004
- Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell MemoryScience, 2003
- CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytesNature, 2003
- Antitumor Immunization with a Minimal Peptide Epitope (G9–209–2M) Leads to a Functionally Heterogeneous CTL ResponseJournal of Immunotherapy, 1999
- Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures.The Journal of cell biology, 1994
- Lysosome-Associated Membrane Protein-1 (LAMP-1) Is the Melanocyte Vesicular Membrane Glycoprotein Band IIJournal of Investigative Dermatology, 1993
- Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartmentsNature, 1991
- Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.The Journal of Experimental Medicine, 1990